Tumor necrosis factor blockade and the risk of viral infection - Wikidata - wikimedia - TriplyDB

Tumor necrosis factor blockade and the risk of viral infection

Tumor necrosis factor blockade and the risk of viral infection

http://www.wikidata.org/entity/Q35161630

about

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies Interferon-beta induces distinct gene expression response patterns in human monocytes versus T cells Herpes simplex virus encephalitis during treatment with etanercept.Potential role of ustekinumab in the treatment of chronic plaque psoriasis Human Cytomegalovirus Latency: Approaching the Gordian Knot.Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.Advances in the medical treatment of rheumatoid arthritis.Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Mechanisms of human autoimmunity.Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function.Superior Orbital Fissure Syndrome and Ophthalmoplegia Caused by Varicella Zoster Virus with No Skin Eruption in a Patient Treated with Tumor Necrosis Alpha Inhibitor.Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-κB Signaling Clinical targeting of the TNF and TNFR superfamilies In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia.Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.Tumour necrosis factor in infectious disease.Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.The intimate relationship between human cytomegalovirus and the dendritic cell lineage.Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection.Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study.Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis.Psoriatic arthritis treatment and the risk of herpes zoster.Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis.Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy.Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan.Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

P2860

Q26830943-C92BBDD5-BE3E-42EC-AABB-256C722AE3FB Q28486504-A7165EEF-7093-42F6-9ECC-9D44485273BC Q30694936-12A91348-70EC-4C4B-B070-6E2EB4140722 Q33892602-FC7C766D-7FD0-4317-A0D5-4BDE7357BCAD Q33912815-4CC9039F-0AB6-4422-A81F-9B665EE0E1B6 Q34068440-4BCBC631-54B8-4ACB-A8DC-5A9019AE2CFA Q35080243-D0762E8A-CE83-4F55-8F7B-D4C7E832D6BB Q35102474-A8218436-6A39-489C-972B-A3BDF48D58A0 Q35620368-2D54E90B-2FD2-4FA2-B202-66A245FC6A7E Q35893711-3BC9C9BA-08DC-44D0-8026-69C071CD56A1 Q35899439-3FB5ADE5-5780-497F-BF59-30BAFEDA15F6 Q35907835-BB3BEA05-9ED9-4AB0-B37B-2795CED955F4 Q36009894-C237433A-B0AE-48EE-B285-8AC1234F3797 Q36265691-107F6DC6-02F0-4CF4-9D46-3BA1971F76BF Q36291639-7D17F537-F9E2-4809-AD30-013D67593822 Q36403492-439C67CD-74C5-4C89-804E-B0D4CEEAED8A Q36762882-C9B4009C-2077-481C-9B91-0BC0E9ACFA6D Q36788495-77E10F76-17BF-40B1-8E78-AECAFBE8E1BE Q36810546-E3F3A709-C5EB-4AC1-9402-A857B0D29655 Q36958237-3A69A4ED-0E4D-4EF9-A42B-D896E072073C Q37576833-B5AE1765-6EBB-4D08-B11D-B5E39ED013CA Q37843179-94EA2DC9-3FC8-428D-B426-15E2E3A99477 Q38086506-1115A750-D3A4-4560-94E0-F48D827C7433 Q38099248-795BD699-8FAF-4E8A-B8D7-3391F4AD7DD5 Q38192553-6EA46545-DD52-43BB-AA0C-EFB62C3E19B0 Q38242199-9C977780-81E1-4DD6-AB41-97A27F6C4511 Q38255412-63ADE395-C425-4A69-B422-6E6CE3DC524E Q38344512-C11448F9-C905-4CA2-A72A-BCC94CE9E26E Q39137483-05159DCC-2325-4730-B93A-E925B9BAFBEC Q40765096-DACE1EF3-197C-484C-B9FA-3BB62A390901 Q40833429-20663A77-3D0F-4E47-ABD4-C9EF4A53D511 Q41049474-DBD32DE4-A8B4-4174-A9E5-17E89BDE4CC2 Q41920067-7393A80A-ADE6-41C7-9D51-A858DC62BD46 Q42242252-53F56F0E-9826-4611-B835-BA68F587C0CE Q42376342-EFC63FC9-0A4C-4E33-90A3-476FA567D3F8 Q43200470-BDD7C2E0-BC12-47E2-8CAE-483FB57F14CD Q45298602-82AA1DF3-095F-4581-997E-0F1A1B720B57 Q45368185-19F3797D-08B2-4CB2-8386-D00EA4E0F9C2 Q48921752-3B4E37FD-369B-4407-9E26-5DCBF201EA1E Q49917457-45E45DB0-99D2-4934-AC04-1254E5C06CBE

P2860

Tumor necrosis factor blockade and the risk of viral infection

http://www.wikidata.org/entity/Q35161630

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Tumor necrosis factor blockade and the risk of viral infection

@ast

Tumor necrosis factor blockade and the risk of viral infection

@en

type

label

Tumor necrosis factor blockade and the risk of viral infection

@ast

Tumor necrosis factor blockade and the risk of viral infection

@en

prefLabel

Tumor necrosis factor blockade and the risk of viral infection

@ast

Tumor necrosis factor blockade and the risk of viral infection

@en

P1433

Q35161630-6BFC30BB-BD33-4388-B519-6F569F3612A1

P1476

Q35161630-88264B87-31AF-47DA-90B5-BE0773B55617

P2093

Q35161630-1BFBD1A0-D784-48E3-8D8E-DEC3AA45E1EA

Q35161630-BFADA470-C935-4546-9BA9-C9768C755A10

P2860

Q35161630-002254C2-F965-4FD3-A2A8-4C8619C21E4E

Q35161630-0124CC09-5AB6-4167-A263-C5A340B35F43

Q35161630-07326E7E-314B-4B2D-A328-104BEC9C030D

Q35161630-07395A8E-4CA1-4897-ACA4-4915FE0278A9

Q35161630-0A007F5F-3911-4542-899B-BE1D28A87647

Q35161630-0B553850-1D50-487D-A6BF-1D786EB67A91

Q35161630-0DF82B7E-903A-487E-9A3D-F709BAA622AD

Q35161630-0EDB46EE-A303-42BB-B53B-175350D43C78

Q35161630-1093C520-86F1-4646-8A87-1E81F6EF8B93

Q35161630-122E6C8C-7195-48F1-AE76-E3F3A217B1E8

P2888

Q35161630-EF05461A-C1DF-4647-89DD-8C22E4FFEE6E

P304

Q35161630-8B9029C9-44C2-44E9-99FC-4F414861B116

P31

Q35161630-D996185A-D595-49BD-A6D8-C8E3976F4A11

P356

Q35161630-53AFA8E3-2226-43BF-AB0B-385241048441

P407

Q35161630-BED0AF3B-BB15-463E-890A-DAFC8024CEB5

P433

Q35161630-94D61005-8A80-45C6-9A32-5BB70143B11D

P478

Q35161630-C36B0384-B528-4BE9-B25C-C9ED4CBC818F

P577

Q35161630-68332C32-90DD-4401-92B0-23779E1A689D

P5875

Q35161630-D379AA20-C79D-42BD-9C64-7D923BAF70E1

P6179

Q35161630-DC767F3A-4A2B-4C6E-8C15-B7DB27F5A22E

P698

Q35161630-38F4CAF7-0C61-4CDB-942B-4DB077D6E1B1

P932

Q35161630-F015599F-6D0E-4DBD-AB0E-FAD51639CDB1

P356

NRRHEUM.2009.279

P1433

Nature Reviews Rheumatology

P1476

Tumor necrosis factor blockade and the risk of viral infection

@en

P2093

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Seo Young Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

CD95's deadly mission in the immune system

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Signalling pathways of the TNF superfamily: a double-edged sword

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

P2888

nrrheum.2009.279

P304

165-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2009.279

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41417146

http://www.w3.org/2001/XMLSchema#string

P6179

1005833893

http://www.w3.org/2001/XMLSchema#string

P698

20142812

http://www.w3.org/2001/XMLSchema#string

P932

3155180

http://www.w3.org/2001/XMLSchema#string